Navigation Links
Covance To Present At The Citi 2013 Global Healthcare Conference
Date:2/22/2013

PRINCETON, N.J., Feb. 22, 2013 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today announced that it will present at the Citi 2013 Global Healthcare Conference on Tuesday, February 26, 2013 at 2:15 p.m. (ET).  Investors may access a live webcast of the presentation at www.covance.com.  In order to register and download any necessary software, please log on 10 minutes early.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues of approximately $2.2 billion, global operations in more than 30 countries, and more than 11,750 employees worldwide.  Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.

Statements contained in this press release, which are not historical facts, such as statements about prospective earnings, savings, revenue, operations, revenue and earnings growth and other financial results are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  All such forward-looking statements including the statements contained herein regarding anticipated trends in the Company's business are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.  These risks and uncertainties include, without limitation, competitive factors, outsourcing trends in the pharmaceutical industry, levels of industry research and development spending, the Company's ability to continue to attract and retain qualified personnel,
'/>"/>

SOURCE Covance Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Covance To Present At The William Blair 32nd Annual Growth Stock Conference
2. Covance Reports Second Quarter Pro Forma Net Revenue Of $538 Million, Pro Forma EPS Of $0.65 And Adjusted Net Orders Of $701 Million
3. Covance to Present at the Morgan Stanley Global Healthcare Conference
4. Covance Reports Third Quarter Pro Forma Net Revenue Of $542 Million, Pro Forma EPS Of $0.72 And Adjusted Net Orders Of $701 Million
5. Covance To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
6. Covance Reports Fourth Quarter Pro Forma Net Revenue Of $561 Million, Pro Forma EPS Of $0.73 And Adjusted Net Orders Of $769 Million
7. Covance To Present At The Leerink Swann Global Healthcare Conference
8. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
9. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
10. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 25, 2014  goBalto, Inc., the leading provider of ... a winner of Red Herring,s Top 100 Global ... North America award in 2013, marking its emergence as ... Red Herring,s Top 100 Global list has become ... and entrepreneurs. Red Herring editors were among the first ...
(Date:11/26/2014)... , Nov. 25, 2014   Heska Corporation ... or the "Company"), a provider of advanced veterinary diagnostic ... Robert Grieve , Executive Chair, will attend The Benchmark Company, ... The one-on-one conference will be held at The Palmer House ... from 8 a.m. to 2:30 p.m. Please email ...
(Date:11/26/2014)... LONDON , Nov. 25, 2014 Amgen ... AZN ) today announced that AMAGINE-2 TM , a pivotal, ... more than 1,800 patients with moderate-to-severe plaque psoriasis, met its ... and placebo at week 12. Brodalumab 210 mg given every ... shown to be superior to Stelara on the primary endpoint ...
Breaking Medicine Technology:goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3Heska to Attend Benchmark Micro Cap Discovery Conference 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10
... 12, 2011 Novartis Pharmaceuticals Corporation ("Novartis") announced ... (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval ... patients with advanced neuroendocrine tumors (NET) of pancreatic ... presentation of data from the everolimus RADIANT (RAD001 ...
... market leading EchoStim® Echogenic Insulated needle has been ... Nerve Blocks (PNBs) using nerve stimulation and ultrasound ... needle has more, brighter, easier to see reflectors, ... practitioners the benefits of using both nerve block ...
Cached Medicine Technology:Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 2Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 3Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 4Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 5Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 6Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 7Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 8Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 9Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 10
(Date:11/26/2014)... Deaf teens have stronger language and reading skills if their ... study suggests. Researchers looked at a group of deaf ... through an infant screening program conducted in the 1990s. ... those who were screened by the time they were 9 ... children who weren,t screened as infants. This new study ...
(Date:11/26/2014)... Nov. 26, 2014 (HealthDay News) -- New regulations to ... plants and factories were issued Wednesday by the U.S. ... asthma, heart disease and premature death. The new ... from 75 parts per billion to between 65 to ... ozone pollution standards in line with the latest science ...
(Date:11/26/2014)... 2014 The report “Laboratory Information ... (On-premise, Hosted, SaaS), End User Labs (Clinical, Molecular ... (Software, Services) - Global Forecast to 2019” provides ... challenges, opportunities, current market trends, and strategies impacting ... forecasts of the revenue and market growth. , ...
(Date:11/26/2014)... Increasing demand for diagnostic imaging ... surgeries has paved way for consequent increase in ... various types of cancers and cardiac diseases globally ... for these owing to their use in diagnosing ... market can also be attributed to advancements in ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Gone are the ... cheap deals on Black Friday, which signifies the beginning of ... items into their shopping carts in the comfort of their ... , This Friday is going to be an occasion ... day, with an estimated $2.48 billion in revenue for online ...
Breaking Medicine News(10 mins):Health News:Spotting Hearing Problems in Infancy May Boost Reading Skills in Deaf Teens 2Health News:EPA Issues Tougher Rules on Ozone Emissions 2Health News:EPA Issues Tougher Rules on Ozone Emissions 3Health News:Laboratory Information Systems Market by Type, Delivery Mode & End Users is Estimated to Reach $1,806.1 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Laboratory Information Systems Market by Type, Delivery Mode & End Users is Estimated to Reach $1,806.1 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Laboratory Information Systems Market by Type, Delivery Mode & End Users is Estimated to Reach $1,806.1 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Contrast Media Injectors Market To 2020 - Global Industry, Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 2Health News:Contrast Media Injectors Market To 2020 - Global Industry, Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 3Health News:2014 Best Friday Deals Revealed by Top10InAction 2
... breakthrough, which could eventually lead to a practical and cost ... the US National Cancer Institute have genetically modified bacteria living ... infection. // ,Most HIV transmission occurs on the ... coated with a layer of bacteria. ,The researchers ...
... Minister Anbumani Ramadoss on Saturday urged the State Government ... 80-year-old Communicable Diseases Hospital (CDH) in Tondiarpet in north ... wards in the hospital, Anbumani told journalists that though ... controlling the cholera outbreak in the city post-rains, the ...
... a 17-year-old teenager named Daniel Hindle of Carvale Drive, Richmond, ... the verdict of 'death by misadventure.' // ,Daniel died ... lip pierced in a salon in the city. He was ... fever. Commenting on the verdict, South Yorkshire coroner ...
... LINK Applied Genomics Programme has proved to be a ... diagnose meningitis, MRSA and Chlamydia; has regenerated spinal nerve ... and has provided effective vaccines against Salmonella. This programme ... collaboration with 23 industrial partners to identify new methods ...
... global problem, the entire world is struggling against the ... as opposed to traditional foods.,Eating patterns are undergoing a ... about this fast food generation growing up. ... to launch a poster campaign to shock children away ...
... bird flu may reduce world energy demand should it evolve ... by more than 1-million barrels a day//. ,World oil ... issued by the US Energy Information Administration. “Should the ... would be profound, potentially reducing energy demand by well over ...
Cached Medicine News:Health News:Genetically modified bacteria to combat HIV 2Health News:Diligence Of Chennai Doctors Appreciated: Anbumani 2Health News:LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems 2Health News:Bird Flu Likely To Reduce World Energy Demand 2
... Brachial Index (ABI) is one of the most simple to perform and useful vascular tests for assessing ... to perform a complete ABI. ... ... ...
... Auto Refractor/Keratometer. Advanced engineering, rapid ... illumination mode make it the most ... 5.5 inch High Quality Monitor ... Rapid, instantaneous readings are taken as ...
A fully automated, benchtop instrument designed for high-volume urine testing, using Siemens' proven technology in dry-pad urine chemistry analysis....
A fully automated, benchtop instrument designed for high-volume urine testing, using Siemens' proven technology in dry-pad urine chemistry analysis....
Medicine Products: